Recently, Fawzy et al. [44] found that H19 circulating levels were significantly increased among patients with T2D, which indicates that it may serve as a blood-based marker of hepatic insulin resistance, especially since its dysregulation has been described in a variety of metabolic disorders. This evidence concerns the gene H19 and type 2 diabetes mellitus.